AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Aastrom Biosciences Reports First Quarter Results.(Brief Article)
2001 NOV 21 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc., (ASTM) has announced financial results for the first fiscal quarter ended September 30, 2001. For the quarter, the company raised approximately $7 million from the sale of common stock through a series of financing transactions. These proceeds have improved the company's ability to fuel its growing development program initiatives for the new fiscal year which includes initiating European sales and marketing of its CE Mark approved products for stem cell therapeutics and dendritic cell vaccines.
For the quarter ended September 30, 2001, the company reported a net loss of $1.9 million, or $.05 per common share, up from a net loss of $1.4 million, or $.04 per common share for the same period in 2000. Revenues, generated by grant funding, for the quarter were $151,000, compared with ...
- Aastrom Biosciences Completes CE Mark Requirements for Third Dendritic Cell...
- Press release article from: PR Newswire August 21, 2003 700+ words
Aastrom Biosciences, Inc. (NasdaqSC: ASTM...requirements to affix the CE Mark on its DCV-II kit in the...production kits to use the CE Mark. The DCV-II kit operates...therapeutic cancer vaccines. The CE Mark allows Aastrom to market...
- Aastrom Biosciences Announces CE Mark Approval For First Dendritic Cell Therapy...
- Press release article from: PR Newswire October 2, 2001 700+ words
...PRNewswire/ -- Aastrom Biosciences, Inc. (Nasdaq...to affix the CE Mark to the DC...subsidiary of Aastrom Biosciences, Inc., located...Europe. About Aastrom Biosciences, Inc. Aastrom...previously received CE Mark approval necessary...
- Aastrom Biosciences Announces CE Mark Approval For Stem Cell Therapy Kit.
- Press release article from: PR Newswire December 17, 1998 700+ words
...PRNewswire/ -- Aastrom Biosciences, Inc. (Nasdaq...to affix the CE Mark to the AastromReplicell...Therapy Kit. "The CE Mark approach to regulatory...has led to the CE Mark which now allows...product line. Aastrom Biosciences, Inc. is pioneering...
- Aastrom Biosciences Announces CE Mark Approval For Cord Blood Therapy Kit.
- Press release article from: PR Newswire February 2, 1999 700+ words
...PRNewswire/ -- Aastrom Biosciences, Inc. (Nasdaq...to affix the CE Mark to the final...to affix the CE Mark to the AastromReplicell...This most recent CE Mark approval demonstrates...product line. Aastrom Biosciences, Inc. is pioneering...
- Aastrom Biosciences receives CE mark for cord blood kit.
- Newspaper article from: Transplant News March 10, 1999 700+ words
Aastrom Biosciences, Inc., Ann Arbor, MI, announced it has obtained approval to affix the CE Mark to the final components of the AastromReplicell...follows earlier approvals to affix the CE Mark to the AastromReplicell System instrumentation...
- Aastrom Biosciences Appoints Audrey Hutter as Vice President Market Operations.
- Press release article from: PR Newswire January 3, 2001 700+ words
...PRNewswire/ -- Aastrom Biosciences, Inc. (Nasdaq...President and CEO of Aastrom Biosciences, Inc. "Aastrom has received CE Mark approval to...this area. Aastrom Biosciences, Inc. is pioneering...has received CE Mark approval, necessary...
- Aastrom Biosciences Completes Second CE Marked Dendritic Cell Therapy Product;...
- Press release article from: PR Newswire February 14, 2002 700+ words
...Mich. -- Aastrom Biosciences, Inc. , announced...to affix the CE Mark to the new...subsidiary of Aastrom Biosciences, Inc., located...Europe. About Aastrom Biosciences, Inc. Aastrom...previously received CE Mark approval necessary...
- Aastrom Biosciences Receives Patent for Adult Bone Marrow Stem Cells; - Patent...
- Press release article from: PR Newswire February 27, 2002 700+ words
...ARBOR, Mich. -- Aastrom Biosciences, Inc. announced...indications. About Aastrom Biosciences, Inc. Aastrom is...previously received CE Mark approval necessary...recently received CE Mark approval necessary...
Source: HighBeam Research, Aastrom Biosciences Reports First Quarter Results.(Brief Article)